Clinical Trial Update: Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma [EARLY_Phase 1]

View source ↗

Summary

This early-phase adaptive therapy study evaluates vismodegib in patients with advanced basal cell carcinoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Vismodegib (Vismodegib)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Advanced Basal Cell Carcinoma | EARLY_Phase 1 | Status: RECRUITING